|
1
|
Islam AD, Naguwa SM, Cheema GS, Hunter JC
and Gershwin ME: Multicentric reticulohistiocytosis: A rare yet
challenging disease. Clin Rev Allergy Immunol. 45:281–289. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baek IW, Yoo SH, Yang H, Park J, Kim KJ
and Cho CS: A case of multicentric reticulohistiocytosis. Mod
Rheumatol. 11:1–4. 2014. View Article : Google Scholar
|
|
3
|
Gorman JD, Danning C, Schumacher HR,
Klippel JH and Davis JC Jr: Multicentric reticulohistiocytosis:
Case report with immunohistochemical analysis and literature
review. Arthritis Rheum. 43:930–938. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bennàssar A, Mas A, Guilabert A, Julià M,
Mascaró-Galy JM and Herrero C: Multicentric reticulohistiocytosis
with elevated cytokine serum levels. J Dermatol. 38:905–910.
2011.PubMed/NCBI
|
|
5
|
de Vries HS, van Oijen MG, Driessen RJ, de
Jong EM, Creemers MC, Kievit W and de Jong DJ: Appropriate
infliximab infusion dosage and monitoring: Results of a panel
meeting of rheumatologists, dermatologists and gastroenterologists.
Br J Clin Pharmacol. 71:7–19. 2011. View Article : Google Scholar :
|
|
6
|
Shannon SE, Schumacher HR, Self S and
Brown AN: Multicentric reticulohistiocytosis responding to tumor
necrosis factor-alpha inhibition in a renal transplant patient. J
Rheumatol. 32:565–567. 2005.PubMed/NCBI
|
|
7
|
Iwata H, Okumura Y, Seishima M and Aoyama
Y: Overexpression of monocyte chemoattractant protein. 1 in the
overlying epidermis of multicentric reticulohistiocytosis lesions:
A case report. Int J Dermatol. 51:492–494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kovach BT, Calamia KT, Walsh JS and
Ginsburg WW: Treatment of multicentric reticulohistiocytosis with
etanercept. Arch Dermatol. 140:919–921. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Broadwell AW, Calamia KT, Kransdorf MJ and
Ginsburg WW: Healing of erosive disease in multicentric
reticulohistiocytosis. J Rheumatol. 37:1366–1367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matejicka C, Morgan GJ and Schlegelmilch
JG: Multicentric reticulohistiocytosis treated successfully with an
anti-tumor necrosis factor agent: Comment on the article by Gorman
et al. Arthritis Rheum. 48:864–866. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lovelace K, Loyd A, Adelson D, Crowson N,
Taylor JR and Cornelison R: Etanercept and the treatment of
multi-centric reticulohistiocytosis. Arch Dermatol. 141:1167–1168.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chauhan A, Mikulik Z and Hackshaw KV:
Multicentric reticu-lohistiocytosis with positive anticyclic
citrullinated antibodies. J Natl Med Assoc. 99:678–680.
2007.PubMed/NCBI
|
|
13
|
Saba R, Kwatra SG, Upadhyay B, Mirrakhimov
AE and Khan FN: Multicentric reticulohistiocytosis presenting with
papulonodular skin lesions and arthritis mutilans. Case Rep
Rheumatol. 2013:2015632013.PubMed/NCBI
|
|
14
|
Sellam J, Deslandre CJ, Dubreuil F, Arfi S
and Kahan A: Refractory multicentric reticulohistiocytosis treated
by infliximab: Two cases. Clin Exp Rheumatol. 23:97–99.
2005.PubMed/NCBI
|
|
15
|
Lee MW, Lee EY, Jeong YI, Choi JH, Moon KC
and Koh JK: Successful treatment of multicentric
reticulohistiocytosis with a combination of infliximab,
prednisolone and methotrexate. Acta Derm Venereol. 84:478–479.
2004.
|
|
16
|
Chiba E, Oda A, Tsutsumi T, Yabe H, Kamiya
Y, Sakurai T, Moriguchi M, Momomura S and Terai C: Case report; a
case with multicentric reticulohistiocytosis successfully treated
with infliximab. Nihon Naika Gakkai Zasshi. 100:483–486. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
De Knop KJ, Aerts NE, Ebo DG, Van Offel
JF, Stevens WJ and De Clerck LS: Multicentric reticulohistiocytosis
associated arthritis responding to anti-TNF and methotrexate. Acta
Clin Belg. 66:66–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Macía-Villa CC and Zea-Mendoza A:
Multicentric reticulohistiocytosis: Case report with response to
infliximab and review of treatment options. Clin Rheumatol. Apr
15–2014.Epub ahead of print.
|
|
19
|
Kalajian AH and Callen JP: Multicentric
reticulohistiocytosis successfully treated with infliximab: An
illustrative case and evaluation of cytokine expression supporting
anti-tumor necrosis factor therapy. Arch Dermatol. 144:1360–1366.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matiz C, Ferguson PJ, Zaenglein A, Groh B
and Bingham CA: Papular xanthomas and erosive arthritis in a 3 year
old girl, is this a new MRH variant? Pediatr Rheumatol Online J.
7:152009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yeter KC and Arkfeld DG: Treatment of
multicentric reticulohistiocytosis with adalimumab, minocycline,
methotrexate. Int J Rheum Dis. 16:105–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tashiro A, Takeuchi S, Nakahara T, Oba J,
Tsujita J, Fukushi J, Kiryu H, Oda Y, Xie L, Yan X, et al: Aberrant
expression of CD10 in ground-glass-like multinucleated giant cells
of multicentric reticulohistiocytosis. J Dermatol. 37:995–997.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma X and Xu S: TNF inhibitor therapy for
rheumatoid arthritis. Biomed Rep. 1:177–184. 2013.
|
|
24
|
Lubrano E, Spadaro A, Amato G, Benucci M,
Cavazzana I, Chimenti MS, Ciancio G, D'Alessandro G, Angelis RD,
Lupoli S, et al: Tumour necrosis factor alpha inhibitor therapy and
rehabilitation for the treatment of ankylosing spondylitis: A
systematic review. Semin Arthritis Rheum. 44:542–550. 2015.
View Article : Google Scholar
|
|
25
|
Behrens F, Cañete JD, Olivieri I, van
Kuijk AW, McHugh N and Combe B: Tumour necrosis factor inhibitor
monotherapy vs combination with MTX in the treatment of PsA: A
systematic review of the literature. Rheumatology (Oxford).
54:915–926. 2015. View Article : Google Scholar
|
|
26
|
Schreiber S: An update on biosimilar drugs
for inflammatory bowel disease. Expert Rev Gastroenterol Hepatol.
9(Suppl 1): 1–3. PubMed/NCBI
|
|
27
|
Jung SM, Kim HS, Kim HR, Kim NY, Lee JH,
Kim J, Kwok SK, Park KS, Park SH, Kim HY and Ju JH: Immunogenicity
of anti-tumour necrosis factor therapy in Korean patients with
rheumatoid arthritis and ankylosing spondylitis. Int
Immunopharmacol. 21:20–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Scheinfeld N: A comprehensive review and
evaluation of the side effects of the tumor necrosis factor alpha
blockers etanercept, infliximab and adalimumab. J Dermatolog Treat.
15:280–294. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Trotta F and Colina M: Multicentric
reticulohistiocytosis and fibroblastic rheumatism. Best Pract Res
Clin Rheumatol. 26:543–557. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ehlers S: Tumor necrosis factor and its
blockade in granulo-matous infections: Differential modes of action
of infliximab and etanercept? Clin Infect Dis. 41(Suppl 3):
S199–S203. 2005. View
Article : Google Scholar
|
|
31
|
Lonsdale-Eccles AA, Haworth AE, McCrae FC
and Young-Min SA: Successful treatment of multicentric
reticulohistiocytosis with leflunomide. Br J Dermatol. 161:470–472.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thalayasingam N and Isaacs JD: Anti-TNF
therapy. Best Pract Res Clin Rheumatol. 25:549–567. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pascual-Salcedo D, Plasencia C, Ramiro S,
Nuño L, Bonilla G, Nagore D, Ruiz Del Agua A, Martínez A, Aarden L,
Martín-Mola E and Balsa A: Influence of immunogenicity on the
efficacy of long-term treatment with infliximab in rheumatoid
arthritis. Rheumatology (Oxford). 50:1445–1452. 2011. View Article : Google Scholar
|
|
34
|
Finckh A, Dudler J, Wermelinger F, Ciurea
A, Kyburz D, Gabay C and Bas S; physicians of SCQM: Influence of
anti-infliximab antibodies and residual infliximab concentrations
on the occurrence of acquired drug resistance to infliximab in
rheumatoid arthritis patients. Joint Bone Spine. 77:313–318. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rosenblum H and Amital H: Anti-TNF
therapy: Safety aspects of taking the risk. Autoimmun Rev.
10:563–568. 2011. View Article : Google Scholar : PubMed/NCBI
|
